Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Gått med maj 2012
5 Foton och videor Foton och videor

Tweets

Du blockerade @AblynxABLX

Är du säker på att du vill visa dessa Tweets? Visning av Tweets kommer inte att häva blockeringen av @AblynxABLX

  1. Retweetade
    26 juli

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 retweets 4 gillanden
  2. Retweetade
    20 juli

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 retweets 7 gillanden
  3. 20 juli

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 svara 9 retweets 14 gillanden
  4. 27 juni

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 retweets 16 gillanden
  5. 26 juni

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 retweets 6 gillanden
  6. 29 maj

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 retweets 9 gillanden
  7. 22 maj

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 retweets 12 gillanden
  8. 18 maj

    Meet our experts and recruiters (booth 99) @

    2 gillanden
  9. 11 maj

    Ablynx zit op schema via

    4 retweets 6 gillanden
  10. 11 maj

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 retweets 4 gillanden
  11. 10 maj

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 retweets 7 gillanden
  12. 2 maj

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 retweets 6 gillanden
  13. 7 apr.

    Annual Report 2016 is available online - view via

    1 retweet 4 gillanden
  14. 7 apr.

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 retweet 4 gillanden
  15. Retweetade
    6 mars

    Compelling data for developed psoriasis nanobody in collaboration

    3 retweets 2 gillanden
  16. Retweetade
    28 feb.

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 svar 51 retweets 103 gillanden
  17. Retweetade
    24 feb.

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 retweet 1 gillande
  18. 23 feb.

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 retweets 3 gillanden
  19. 9 feb.

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 retweets 2 gillanden
  20. 6 feb.

    Ablynx files caplacizumab for ultra rare blood disorder
    6 retweets 9 gillanden

@AblynxABLX har inte Tweetat än.

Hämtningen verkar ta ett tag

Twitter kan vara överbelastat eller ha tillfälliga problem. Försök igen eller besök Twitter Status om du vill ha mer information.

    Du kanske också gillar

    ·